Cargando…

Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei

BACKGROUND: The Tropheryma whipplei causes acute gastroenteritis to neuronal damages in Homo sapiens. Genomics and codon adaptation studies would be helpful advancements of disease evolution prediction, prevention, and treatment of disease. The codon usage data and codon usage measurement tools were...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Amit, Krishnan, Sunil, Kaushik, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899776/
https://www.ncbi.nlm.nih.gov/pubmed/35254546
http://dx.doi.org/10.1186/s43141-022-00324-5
_version_ 1784663980574244864
author Joshi, Amit
Krishnan, Sunil
Kaushik, Vikas
author_facet Joshi, Amit
Krishnan, Sunil
Kaushik, Vikas
author_sort Joshi, Amit
collection PubMed
description BACKGROUND: The Tropheryma whipplei causes acute gastroenteritis to neuronal damages in Homo sapiens. Genomics and codon adaptation studies would be helpful advancements of disease evolution prediction, prevention, and treatment of disease. The codon usage data and codon usage measurement tools were deployed to detect the rare, very rare codons, and also synonymous codons usage. The higher effective number of codon usage values indicates the low codon usage bias in T. whipplei and also in the 23S and 16S ribosomal RNA genes. RESULTS: In T. whipplei, it was found to hold low codon biasness in genomic sets. The synonymous codons possess the base content in 3rd position that was calculated as A3S% (24.47 and 22.88), C3S% (20.99 and 22.88), T3S% (21.47 and 19.53), and G3S% (33.08 and 34.71) for 23s and 16s rRNA, respectively. CONCLUSION: Amino acids like valine, aspartate, leucine, and phenylalanine hold high codon usage frequency and also found to be present in epitopes KPSYLSALSAHLNDK and FKSFNYNVAIGVRQP that were screened from proteins excinuclease ABC subunit UvrC and 3-oxoacyl-ACP reductase FabG, respectively. This method opens novel ways to determine epitope-based peptide vaccines against different pathogenic organisms.
format Online
Article
Text
id pubmed-8899776
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88997762022-03-07 Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei Joshi, Amit Krishnan, Sunil Kaushik, Vikas J Genet Eng Biotechnol Research BACKGROUND: The Tropheryma whipplei causes acute gastroenteritis to neuronal damages in Homo sapiens. Genomics and codon adaptation studies would be helpful advancements of disease evolution prediction, prevention, and treatment of disease. The codon usage data and codon usage measurement tools were deployed to detect the rare, very rare codons, and also synonymous codons usage. The higher effective number of codon usage values indicates the low codon usage bias in T. whipplei and also in the 23S and 16S ribosomal RNA genes. RESULTS: In T. whipplei, it was found to hold low codon biasness in genomic sets. The synonymous codons possess the base content in 3rd position that was calculated as A3S% (24.47 and 22.88), C3S% (20.99 and 22.88), T3S% (21.47 and 19.53), and G3S% (33.08 and 34.71) for 23s and 16s rRNA, respectively. CONCLUSION: Amino acids like valine, aspartate, leucine, and phenylalanine hold high codon usage frequency and also found to be present in epitopes KPSYLSALSAHLNDK and FKSFNYNVAIGVRQP that were screened from proteins excinuclease ABC subunit UvrC and 3-oxoacyl-ACP reductase FabG, respectively. This method opens novel ways to determine epitope-based peptide vaccines against different pathogenic organisms. Springer Berlin Heidelberg 2022-03-07 /pmc/articles/PMC8899776/ /pubmed/35254546 http://dx.doi.org/10.1186/s43141-022-00324-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Joshi, Amit
Krishnan, Sunil
Kaushik, Vikas
Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
title Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
title_full Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
title_fullStr Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
title_full_unstemmed Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
title_short Codon usage studies and epitope-based peptide vaccine prediction against Tropheryma whipplei
title_sort codon usage studies and epitope-based peptide vaccine prediction against tropheryma whipplei
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899776/
https://www.ncbi.nlm.nih.gov/pubmed/35254546
http://dx.doi.org/10.1186/s43141-022-00324-5
work_keys_str_mv AT joshiamit codonusagestudiesandepitopebasedpeptidevaccinepredictionagainsttropherymawhipplei
AT krishnansunil codonusagestudiesandepitopebasedpeptidevaccinepredictionagainsttropherymawhipplei
AT kaushikvikas codonusagestudiesandepitopebasedpeptidevaccinepredictionagainsttropherymawhipplei